Literature DB >> 16739180

Bioactivity in in situ hydroxyapatite-polycaprolactone composites.

Devendra Verma1, Kalpana Katti, Dinesh Katti.   

Abstract

In our previous work, hydroxyapatite (HAP) was synthesized under two conditions: one in the presence of polyacrylic acid (in situ HAP) and the other in the absence of polyacrylic acid (ex situ HAP). Composites of both HAPs with polycaprolactone (PCL) were investigated for their applicability as scaffolds for bone tissue engineering. In the current work, bioactivity of these composites has been investigated by soaking them in simulated body fluid for different intervals of time. Nucleation and growth mechanism of apatite on these composites has also been investigated. Fourier transform infrared spectroscopy study suggests that although apatite growth starts with an intermediate phase, it completely transforms to HAP after 4 days of soaking. Nanoindentation results suggest that the apatite growing on in situ HAP/PCL composites has much higher hardness and elastic modulus as compared to the apatite growing on ex situ HAP/PCL composites. The apatite grown on the ex situ composites has a net-like interconnected structure. The observed differences in mechanical properties and morphology of apatite have been described on the basis of nucleation mechanisms. The nucleation of apatite on the in situ HAP/PCL composites proceeds through the formation of a complex between Ca2+ and COO- groups; on the other hand, nucleation occurs because of dissolution reaction of apatite in ex situ HAP/PCL composites. 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739180     DOI: 10.1002/jbm.a.30774

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  9 in total

Review 1.  FT-IR imaging of native and tissue-engineered bone and cartilage.

Authors:  Adele Boskey; Nancy Pleshko Camacho
Journal:  Biomaterials       Date:  2006-12-18       Impact factor: 12.479

Review 2.  Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel.

Authors:  Liam C Palmer; Christina J Newcomb; Stuart R Kaltz; Erik D Spoerke; Samuel I Stupp
Journal:  Chem Rev       Date:  2008-11       Impact factor: 60.622

Review 3.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

4.  A study on mineralization behavior of amino-terminated hyperbranched polybenzimidazole membranes.

Authors:  Xiayun Huang; Hongcui Cao; Zixing Shi; Hongjie Xu; Jianhua Fang; Jie Yin; Qiaoling Pan
Journal:  J Mater Sci Mater Med       Date:  2010-04-07       Impact factor: 3.896

5.  Bacteriophage Bundles with Pre-Aligned Ca Initiate the Oriented Nucleation and Growth of Hydroxylapatite.

Authors:  Fuke Wang; Binrui Cao; Chuanbin Mao
Journal:  Chem Mater       Date:  2010-06-22       Impact factor: 9.811

6.  Self-assembly and mineralization of genetically modifiable biological nanofibers driven by β-structure formation.

Authors:  Hong Xu; Binrui Cao; Anne George; Chuanbin Mao
Journal:  Biomacromolecules       Date:  2011-05-10       Impact factor: 6.988

7.  Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering.

Authors:  Weichang Xue; Amit Bandyopadhyay; Susmita Bose
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-11       Impact factor: 3.368

8.  Porous scaffolds of polycaprolactone reinforced with in situ generated hydroxyapatite for bone tissue engineering.

Authors:  Paola Fabbri; Federica Bondioli; Massimo Messori; Cristina Bartoli; Dinuccio Dinucci; Federica Chiellini
Journal:  J Mater Sci Mater Med       Date:  2009-08-04       Impact factor: 3.896

Review 9.  Fabrication, Properties and Applications of Dense Hydroxyapatite: A Review.

Authors:  Mythili Prakasam; Janis Locs; Kristine Salma-Ancane; Dagnija Loca; Alain Largeteau; Liga Berzina-Cimdina
Journal:  J Funct Biomater       Date:  2015-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.